21st Austria weekly - Erste Group; Marinomed (28/02/2025)

Erste Group: Erste Group Bank AG posted an operating result of 5.9 billion euros (+6.6%) in 2024 on the back of strong growth in customer business. The net result attributable to owners of the parent rose to EUR 3,125 million (EUR 2,998 million) on the back of the strong operating result.Customer loans rose significantly to 218.1 billion euros (+4.9%), with growth dynamics slightly stronger in Central and Eastern Europe (CEE). After somewhat weaker demand in the first half of the year, the appetite for loans grew in the fourth quarter. Deposits too increased to 241.7 billion euros (+3.8%). “Our results show that we are active in Europe's growth region, with two-thirds of our profits coming from our banks in Central and Eastern Europe. The pursuit of prosperity here remains unbroken, despite the strong convergence over the past 20 years. This region is also where future potential lies. In view of the major geopolitical changes taking place, Europe needs to grow closer together,” says Peter Bosek, CEO of Erste Group.
Erste Group: weekly performance: -2.50%

Marinomed: Marinomed Biotech AG (VSE:MARI) announces the successful closing of the sale of the Carragelose business to French CDMO (contract development and manufacturing organization) Unither Pharmaceuticals. All necessary conditions for completing the transaction have been met: The contract provides for upfront and milestone payments in total of up to EUR 20 million, including an upfront payment of up to EUR 5 million associated with closing of the deal. Further payments depend on the achievement of defined commercial and operational targets over the next two years. The agreement provides for the transfer of the entire Carragelose portfolio, including all associated agreements and business relations. As part of the agreement, Marinomed and Unither also entered into a transition service agreement covering services in the areas of regulatory affairs, business development or research & development.
Marinomed Biotech: weekly performance: -2.80%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (28/02/2025)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1132: ATX etwas fester, Addiko Prediction stimmte; Frequentis, Telekom und Polytec gesucht

Bildnachweis

1. 21st Austria Weekly

Aktien auf dem Radar:Rosenbauer, RBI, DO&CO, Semperit, Austriacard Holdings AG, EuroTeleSites AG, Porr, Amag, Andritz, AT&S, VIG, Uniqa, Palfinger, Polytec Group, Marinomed Biotech, OMV, Addiko Bank, Erste Group, Flughafen Wien, Lenzing, Mayr-Melnhof, RWT AG, Strabag, Wienerberger, BKS Bank Stamm, BTV AG, Oberbank AG Stamm, CA Immo, CPI Europe AG, Österreichische Post, Telekom Austria.

Random Partner

---

wikifolio
wikifolio ging 2012 online und ist heute Europas führende Online-Plattform mit Handelsstrategien für alle Anleger, die Wert auf smarte Geldanlage legen. wikifolio Trader, darunter auch Vollzeitinvestoren, erfolgreiche Unternehmer, Experten bestimmter Branchen, Vermögensverwalter oder Finanzredaktionen, teilen ihre Handelsideen in Musterportfolios, den wikifolios.

>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner